Unraveling Cancer Pain Dynamics

This adaptive learning program is designed for healthcare professionals involved in cancer pain management. Tailored to your existing knowledge, it allows you to "test out" of topics you already master. In this fully interactive course, clinicians will explore the safe and effective use of opioid analgesics, optimize non-opioid analgesics and adjuvant medications, and learn to integrate non-pharmacological approaches into comprehensive cancer pain management. Key topics include opioid safety, pain management strategies, non-opioid therapies, and holistic approaches to patient care.

The goal of this initiative is to provide education to clinicians, involved in the assessment and management of cancer pain in adult patients, on the appropriate and safe use of opioid analgesics, optimizing non-opioid analgesics and adjuvant medications, and integrating non-pharmacological approaches into cancer pain management. 

Provided by the National Comprehensive Cancer Network in collaboration with The France Foundation.

Target Audience

This program is designed to meet the educational needs of health care professionals specializing in oncology, hematology, pain management, psychology, primary care (including family medicine and internal medicine), and emergency medicine. This includes physicians, physician assistants/physician associates, nurse practitioners, pharmacists, nurses, and other health care professionals engaged in the management of cancer pain in adult patients, whether or not they have prescribing authority for controlled substances.

Learning Objectives

Following this program, participants should be able to:

  • Recall the underlying principles of pain management in oncology, including cancer-specific pain definitions and mechanisms relevant to different types of cancer.
  • Describe the steps for assessing pain in patients with cancer, recognizing cancer-related pain patterns, and identifying risk factors for substance use disorders.
  • Evaluate the range of therapeutic modalities for managing pain, including non-pharmacological strategies and appropriate use of non-opioid and opioid analgesics.
  • Explain how to integrate opioid analgesics into individualized treatment plans for cancer pain, considering the unique characteristics and needs of patients with different types of cancer, while continuously assessing for functional improvement.
  • Summarize how to safely initiate, titrate, and discontinue opioid analgesics for acute and chronic cancer pain following evidence-based practices and patient-centered care principles.
  • Describe how to provide effective counseling to patients and caregivers regarding the safe use, storage, and disposal of opioid analgesics.
  • Recognize scenarios for referral to a pain specialist and collaborate effectively with interdisciplinary teams to optimize pain management, including the identification and management of opioid use disorders.
Additional information
Supporters: 

This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies.

Please see https://opioidanalgesicrems.com/Resources/Docs/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements that are issued by the US Food and Drug Administration (FDA).

Course summary
Available credit: 
  • 1.00 AAPA Category 1 CME credit
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 ASWB continuing education credit
  • 1.00 Participation
Course opens: 
12/16/2024
Course expires: 
10/31/2025
Cost:
$0.00

Sorin Buga, MD
Clinical Professor, Department of Supportive Care Medicine
Program Director, COH Hospice and Palliative Medicine Fellowship
City of Hope
Duarte, CA

David Copenhaver, MD, MPH
Chief, Division of Pain Medicine
Director, Cancer Pain Management & Supportive Care
Director, Pain Tele-Health programs
Clinical Professor, Division of Pain Medicine
UC Davis Health
Sacramento, CA

David S. Craig, PharmD
Pharmacist Lead, Acute Pain and Supportive Care Medicine
Moffitt Cancer Center
Tampa, FL

Dwain Fehon, PsyD
Professor of Psychology
Chief Psychologist, Psychiatric Services, Yale New Haven Hospital;
Director, Behavioral Medicine Service
Yale School of Medicine 
New Haven, CT

Myra Glajchen, DSW, MSW, BSW, ACSW, APHSW-C 
Director of Education and Training
ESPEC Project Director
Associate Program Director, Fellowship Training Program
MJHS Institute for Innovation in Palliative Care
New York, NY

Elizabeth Prsic, MD
Director, Adult Inpatient Palliative Care 
Firm Chief, Medical Oncology
Yale Cancer Center
Assistant Professor, Yale School of Medicine
New Haven, CT

Carey Ramirez, ANP-C, ACHPN
Manager, Advanced Practice 
Supportive Care Medicine 
City of Hope 
Duarte, CA

Erin Vipler, MD
Assistant Professor, Medicine-Internal Medicine
University of Colorado Hospital
Aurora, CO

Jeanie Youngwerth, MD, FAAHPM
Associate Professor of Medicine
UCH Medical Staff President
Associate Program Director, Colorado Palliative Medicine Fellowship
Director, Palliative Care Service
Department of Medicine
University of Colorado Anschutz Medical Campus
Aurora, CO
 

NCCN Continuing Education Disclosure Policy
It is the policy of NCCN that all planners, faculty, moderators, authors, reviewers and anyone involved in the planning and delivery of NCCN continuing education activities are expected to disclose ALL financial relationships they have had in the past 24 months with ineligible companies. The ACCME Standards for Integrity and Independence require that individuals who refuse to provide this information will be disqualified from involvement in the planning and implementation of accredited continuing education presented by NCCN. NCCN identifies, mitigates and discloses to learners all relevant financial relationships.

In addition, all content has been reviewed to ensure education promotes safe, effective patient care and does not promote the products or services of an ineligible company. Content, including any presentation of therapeutic options, is fair, balanced, evidence-based, scientifically accurate, and free of commercial bias and marketing. 

Definitions  

Ineligible Company: An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. 

Relevant Financial Relationships: Financial relationships of any dollar amount occurring within the past 24 months are defined as relevant if the educational content an individual can control is related to the business lines or products of an ineligible company. There is no minimum financial threshold. We ask for disclosure of ALL financial relationships with ineligible companies, regardless of the amount and regardless of the potential relevance of each relationship to the education.

Faculty Disclaimers  

All faculty for this continuing education activity are competent in the subject matter and qualified by experience, training, and/or preparation for the tasks and methods of delivery.

Faculty presentations may include discussion of off-label use. Faculty will disclose that the use in question is not currently approved by the FDA per the product labeling or marketing.

Faculty Disclosures

The faculty listed below have no financial relationships with ineligible companies to disclose.

David Copenhaver, MD, MPH
Dwain Fehon, PsyD
Myra Glajchen, DSW, MSW, BSW, ACSW, APHSW-C
Elizabeth Prsic, MD
Carey Ramirez, ANP-C, ACHPN
Erin Vipler, MD
Jeanie Youngwerth, MD, FAAHPM

The faculty listed below have the following relevant financial relationship(s) with ineligible companies to disclose. All of the relevant financial relationships listed for these individuals have been mitigated.

Sorin Buga, MD
Bausch Health US LLS: Non-CE Consulting

David S. Craig, PharmD
PCORI: Contract Research
Seikagaku Corporation: Non-CE Consulting (relationship ended August 2024)
Syneos Health, LLC: Non-CE Consulting (relationship ended February 2023)
USM, LLC: Non-CE Consulting (relationship ended May 2023)

NCCN and The France Foundation Staff Disclosures

None of the planners for this educational activity have relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

In support of improving patient care, National Comprehensive Cancer Network (NCCN) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physicians
NCCN designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses
NCCN designates this educational activity for a maximum of 1.0 contact hour.

Pharmacists
NCCN designates this knowledge-based continuing education activity for 1.0 contact hour (0.1 CEUs) of continuing education credit. UAN: JA4008196-0000-24-100-H08-P

PAs
NCCN has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. Approval is valid until October 31, 2025. PAs should only claim credit commensurate with the extent of their participation.

Social Workers
As a Jointly Accredited Organization, NCCN is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. NCCN maintains responsibility for this course. Social workers completing this course receive 1.0 continuing education credit.

Available Credit

  • 1.00 AAPA Category 1 CME credit
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 ASWB continuing education credit
  • 1.00 Participation

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

This site and its activities are best viewed using the latest versions of the Chrome, Edge, Firefox, and Safari browsers.
Additionally, this site and its activities are best viewed using the latest operating system for your device.